NEUBASE THERAPEUTICS INC

CUSIP: 64132K102 Class: COM

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 376,758 Value ($000) $70 Avg Close — Range —
Q4 2022
Shares 945,674 Value ($000) $180 Avg Close — Range —
Q3 2022
Shares 1,059,054 Value ($000) $419 Avg Close — Range —
Q2 2022
Shares 1,059,054 Value ($000) $1,112 Avg Close — Range —
Q1 2022
Shares 1,059,054 Value ($000) $1,991 Avg Close — Range —
Q4 2021
Shares 1,364,634 Value ($000) $3,834 Avg Close — Range —
Q3 2021
Shares 1,366,330 Value ($000) $4,932 Avg Close — Range —
Q2 2021
Shares 1,297,848 Value ($000) $6,217 Avg Close — Range —
Q1 2021
Shares 958,831 Value ($000) $7,086 Avg Close — Range —
Q4 2020
Shares 924,901 Value ($000) $6,465 Avg Close — Range —
Q3 2020
Shares 916,553 Value ($000) $6,957 Avg Close — Range —
Q2 2020
Shares 128,588 Value ($000) $1,129 Avg Close — Range —
Q1 2020
Shares 41,097 Value ($000) $293 Avg Close — Range —
Q4 2019
Shares 41,097 Value ($000) $296 Avg Close — Range —
Q3 2019
Shares 41,097 Value ($000) $205 Avg Close — Range —